Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.
Dobaño C, Santano R, Jiménez A, Vidal M, Chi J, Rodrigo Melero N, Popovic M, López-Aladid R, Fernández-Barat L, Tortajada M, Carmona-Torre F, Reina G, Torres A, Mayor A, Carolis C, García-Basteiro AL, Aguilar R, Moncunill G, Izquierdo L.
Dobaño C, et al. Among authors: torres a.
Transl Res. 2021 Jun;232:60-74. doi: 10.1016/j.trsl.2021.02.006. Epub 2021 Feb 12.
Transl Res. 2021.
PMID: 33582244
Free PMC article.